JPMORGAN CHASE & CO - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$127,994
-7.7%
74,415
+4.6%
0.00%
Q2 2023$138,697
+43.0%
71,127
+102.2%
0.00%
Q1 2023$97,000
+94074.8%
35,176
+17.6%
0.00%
Q4 2022$103
-99.1%
29,921
+525.6%
0.00%
Q3 2022$12,000
+71.4%
4,783
+71.5%
0.00%
Q2 2022$7,000
-97.4%
2,789
-95.8%
0.00%
Q1 2022$273,000
-65.5%
66,140
+7.4%
0.00%
Q4 2021$792,000
-38.5%
61,583
-48.3%
0.00%
Q3 2021$1,287,000
+29.6%
119,231
+9.7%
0.00%
Q2 2021$993,000
-71.9%
108,705
-71.0%
0.00%
Q1 2021$3,534,000
+418.9%
374,781
+116.9%
0.00%
Q4 2020$681,000
+44.9%
172,816
-2.7%
0.00%
Q3 2020$470,000
-76.9%
177,615
-42.1%
0.00%
Q2 2020$2,037,000
+146.9%
306,978
+116.4%
0.00%
Q1 2020$825,000
-30.3%
141,886
+7.6%
0.00%
Q4 2019$1,183,000
+9.1%
131,921
+5.1%
0.00%
Q3 2019$1,084,000
-10.0%
125,470
+4.0%
0.00%
Q2 2019$1,204,000
-24.0%
120,595
+1.3%
0.00%
Q1 2019$1,584,000
-16.9%
119,088
-3.5%
0.00%
Q4 2018$1,906,000
-7.7%
123,368
-14.9%
0.00%
Q3 2018$2,065,000145,0000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders